🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/05/2010 | 30,41 | 30,83 | 30,16 | 30,40 | -0,56% | 2,20% | 13.930.016 |
| 21/05/2010 | 29,77 | 30,68 | 29,62 | 30,57 | +0,69% | 3,56% | 26.721.694 |
| 20/05/2010 | 30,75 | 31,06 | 30,30 | 30,36 | -2,45% | 2,48% | 25.881.198 |
| 19/05/2010 | 30,73 | 31,39 | 30,60 | 31,13 | +0,83% | 2,58% | 22.192.134 |
| 18/05/2010 | 31,46 | 31,49 | 30,82 | 30,87 | -1,31% | 2,12% | 19.165.195 |
| 17/05/2010 | 31,41 | 31,55 | 30,71 | 31,28 | -0,30% | 2,67% | 16.146.222 |
| 14/05/2010 | 31,82 | 31,82 | 31,18 | 31,37 | -1,29% | 2,01% | 22.117.621 |
| 13/05/2010 | 32,14 | 32,20 | 31,59 | 31,78 | -0,98% | 1,90% | 15.354.353 |
| 12/05/2010 | 32,41 | 32,48 | 31,90 | 32,10 | +0,39% | 1,80% | 20.002.442 |
| 11/05/2010 | 31,82 | 32,55 | 31,52 | 31,98 | -2,16% | 3,24% | 25.819.786 |
| 10/05/2010 | 32,37 | 33,26 | 32,34 | 32,68 | +2,27% | 2,86% | 24.561.976 |
| 07/05/2010 | 32,36 | 32,65 | 31,44 | 31,96 | -2,28% | 3,75% | 27.703.775 |
| 06/05/2010 | 33,79 | 33,95 | 29,29 | 32,70 | -3,71% | 13,78% | 32.246.750 |
| 05/05/2010 | 33,80 | 34,13 | 33,30 | 33,96 | -0,61% | 2,46% | 22.489.661 |
| 04/05/2010 | 33,97 | 34,69 | 33,97 | 34,17 | +1,53% | 2,13% | 33.995.967 |
| 03/05/2010 | 33,67 | 33,81 | 33,44 | 33,65 | +0,66% | 1,11% | 13.021.190 |
| 30/04/2010 | 33,71 | 34,16 | 33,43 | 33,44 | -0,60% | 2,18% | 16.476.342 |
| 29/04/2010 | 33,38 | 33,98 | 33,38 | 33,64 | +2,00% | 1,80% | 19.118.454 |
| 28/04/2010 | 32,92 | 33,21 | 32,63 | 32,98 | +0,23% | 1,74% | 17.689.716 |
| 27/04/2010 | 33,25 | 33,86 | 32,83 | 32,90 | -1,49% | 3,07% | 20.457.694 |
| 26/04/2010 | 33,95 | 34,31 | 33,30 | 33,40 | -1,30% | 2,98% | 27.871.979 |
| 23/04/2010 | 32,29 | 34,12 | 32,00 | 33,84 | +5,00% | 6,56% | 43.319.185 |
| 22/04/2010 | 32,99 | 33,06 | 32,21 | 32,22 | -2,79% | 2,57% | 40.059.695 |
| 21/04/2010 | 34,44 | 34,52 | 33,11 | 33,15 | -3,66% | 4,10% | 38.975.015 |
| 20/04/2010 | 34,40 | 34,73 | 34,23 | 34,41 | +0,45% | 1,47% | 10.639.506 |
| 19/04/2010 | 34,05 | 34,33 | 33,67 | 34,26 | +0,53% | 1,93% | 13.147.998 |
| 16/04/2010 | 34,34 | 34,51 | 33,75 | 34,07 | -0,92% | 2,22% | 21.576.538 |
| 15/04/2010 | 34,56 | 34,83 | 34,31 | 34,39 | -0,47% | 1,49% | 21.771.152 |
| 14/04/2010 | 35,06 | 35,06 | 34,36 | 34,55 | -1,34% | 1,99% | 20.934.534 |
| 13/04/2010 | 35,01 | 35,24 | 34,90 | 35,02 | -0,41% | 0,95% | 12.493.942 |